◈ Nootpedia

This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

High-risk compound

Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-PERMANENT — risk:benefit fails for the canonical archetype.

Browse

Gabapentin

Extensively Studied

Gabapentin is a 1974 Goedecke/Parke-Davis lipophilic GABA analog that turned out to have nothing to do with GABA — it binds the α2δ-1…

Aliases (7)
Neurontin · Gralise · Horizant (gabapentin enacarbil prodrug — separate entry warranted but overlaps) · GBP · 1-(aminomethyl)cyclohexaneacetic acid · CI-945 · GOE-3450
TYPICAL DOSE
300 mg
BID
ROUTE
Oral (tablet)
Oral
CYCLE
not applicable
As prescribed
STORAGE
Room temp; original container
Room temp

Overview

What is Gabapentin?

Gabapentin (Neurontin) is an anticonvulsant FDA-approved for partial seizures and postherpetic neuralgia. Off-label use is widespread for neuropathic pain, anxiety, alcohol withdrawal, and restless legs.

Key Benefits

Reduces neuropathic pain, anxiolytic at higher doses, supports sleep, useful in alcohol withdrawal and restless legs syndrome. Generally safer than benzodiazepines for anxiety with lower addiction potential.

Mechanism of Action

Binds the alpha-2-delta subunit of voltage-gated calcium channels, reducing calcium influx and excitatory neurotransmitter release (glutamate, norepinephrine, substance P) in hyperexcited neurons. Despite the name, does not act on GABA receptors.

Pharmacokinetics

—·—
PeakHalf-life
Approximate curve — visual aid only, not data-precise PK
▸Brand options5 known
NeurontinGraliseGBPCI-945GOE-3450

StatusRx (US — federally not DEA-scheduled). Schedule V controlled in 7 US jurisdictions as of Dec 2024 (Kentucky 2017, West Virginia 2018, Tennessee 2018, Michigan 2019, Virginia 2019, Alabama 2019, North Dakota 2019; Utah and Kansas have PDMP-only requirements). UK Class C / Schedule 3 (since April 2019). POM in EU.

Research Indications

Most Effective

The "GABA" misnomer — chemistry history, not pharmacology

Gabapentin (1-(aminomethyl)cyclohexaneacetic acid, formerly CI-945, GOE-3450) was synthesized in 1974-75 at Goedecke AG, Freiburg, German…

Effective

What gabapentin actually does — α2δ subunit binding

Voltage-gated calcium channels (VGCCs) are heteromeric — they have a pore-forming α1 subunit (Cav1.x, Cav2.x, Cav3.x) plus auxiliary β, γ…

Investigational

Newer (2024-2025) mechanism layer — synaptogenesis via thrombospondin

α2δ-1 turns out to also be the major synaptogenic neuronal receptor for thrombospondins (TSP-1, TSP-4) — astrocyte-secreted matricellular…

Investigational

Pharmacokinetics — the saturable absorption gotcha

- Absorption: solely via L-amino acid transporter 1 (LAT1) in small intestine. This transporter is saturable, which produces gabapentin's…

Investigational

Why gabapentin is not pregabalin

Both bind α2δ-1. Differences that matter: - Pregabalin has 90%+ bioavailability and linear PK (no saturable absorption — uses LAT1 too bu…

Peptide Interactions

TCAs (amitriptyline, nortriptyline) for neuropathic pain
Synergistic

additive analgesia, both well-established. Watch combined sedation.

Duloxetine
Synergistic

additive in DPN per ACCORD-style combination data.

opioids
Avoid

additive respiratory depression; documented mortality signal. Hard avoid for users in this archetype (not on opioids, but flag for awareness).

benzodiazepines
Avoid

additive CNS depression.

phenibut, baclofen, alcohol, GHB
Avoid

same family of GABAergic / α2δ / GHB-receptor depressants; stack creates respiratory depression / coma risk.

pregabalin
Avoid

same mechanism, redundant.

modafinil
Avoid

directly antagonistic to the user's V stack wakefulness goal (gabapentin sedates, modafinil promotes wake).

Antacids / aluminum-magnesium
Compatible

reduce gabapentin absorption ~20% — separate by 2 h.

No CYP interactions
Compatible

neutral with most psychiatric and supplement stack components.

Quality Indicators

✓

Pharmacy-dispensed, intact packaging

Prescription tablets in original sealed packaging from a licensed pharmacy.

!

Generic vs branded

Generics are usually fine but bioavailability can vary slightly; track if you switch.

✗

Unbranded blister or counterfeit risk

Counterfeit pharmaceuticals are a known issue; verify pharmacy and lot if buying internationally.

What to Expect

  • Onset
    1-2 hours oral, faster intranasal.
  • Onset
    12 hours to 7 days after abrupt discontinuation. Faster onset with shorter use; gradual onset with chronic use.

Side Effects & Safety 15

Side Effects

  1. 1Somnolence (~20%)
  2. 2Dizziness / lightheadedness (~17%)
  3. 3Ataxia / unsteady gait (~13%)
  4. 4Peripheral edema (5-10% chronic users)
  5. 5Fatigue (~11%)
  6. 6Cognitive blunting / brain fog (variable; common but underreported in trial AE tables)
  7. 7Weight gain (modest, dose-related, mechanism unclear — possibly carbohydrate-craving and edema)
  8. 8Nystagmus
  9. 9Tremor
  10. 10Diplopia / blurred vision
  11. 11Dry mouth
  12. 12Constipation
  13. 13Headache (paradoxical)
  14. 14Mood lability
  15. 15Nervousness or irritability (paradoxical, usually early)

When to Stop

  • Respiratory depression — especially with concomitant opioids, benzodiazepines, alcohol, or in COPD/sleep apnea patients. FDA added a Boxed Warning (2019, expanded since) about serious breathing problems. Mechanism: additive CNS depression. In population-based cohort studies, concurrent gabapentin + opioids increases opioid-related death by 49-98% depending on dose.
  • Suicidal ideation (FDA class warning for all anticonvulsants, 2008) — small absolute risk increase, mechanism uncertain, screen at initiation.
  • DRESS / multi-organ hypersensitivity. Rare but reported. Watch first 8-12 weeks.
  • Stevens-Johnson syndrome. Rare.
  • Pancreatitis. Rare case reports.
  • Acute kidney injury in dehydrated / renally compromised users.
  • Withdrawal seizures on abrupt discontinuation in long-term users.
  • Dependence syndrome (DSM-5 substance use disorder pattern) — characterized by tolerance, escalating doses, craving, withdrawal, continued use despite harm. Documented in:
  • General population: ~1% prevalence
  • Prescription holders: 40-65% misuse some time during their prescription
  • Opioid-using populations: 15-22% misuse
  • Mortality: ~5,000 US gabapentin-involved overdose deaths per year (2020-2024 average), almost always polypharmacy, ~90% co-involve opioids.
  • First 2 weeks: sedation peak, fall risk especially in older users, suicidal ideation screen.
  • First 8-12 weeks: DRESS / hypersensitivity window.
  • Discontinuation: never abrupt. Taper 10-25% per week minimum if used >1 month.

References

Gabapentin — Wikipedia

en.wikipedia.org

high-level history, FDA approval timeline, regulatory status.

View Study

Pharmacological disruption of calcium channel trafficking by the α2δ ligand gabapentin — PNAS

pnas.org

canonical mechanism paper on trafficking, not pore block.

View Study

Mechanisms of the gabapentinoids and α2δ-1 calcium channel subunit in neuropathic pain — PMC

pmc.ncbi.nlm.nih.gov

review of α2δ-1 mechanism in neuropathic pain.

View Study

Mechanism of Analgesia by Gabapentinoid Drugs: Involvement of Modulation of Synaptogenesis and Trafficking of Glutamate-Gated Ion Channels — JPET 2024

jpet.aspetjournals.org · 2024

17143-1/fulltext) — 2024 mechanism update emphasizing synaptogenesis modulation via thrombospondin-α2δ-1 axis.

View Study

Calcium Channel α2δ Ligands Mirogabalin, Pregabalin, and Gabapentin — Pain and Therapy 2025

link.springer.com · 2025

comparative pharmacology and DPN therapeutics review.

View Study
Was this helpful?
Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…
✎

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load ▸
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources

Related compounds

Cross-referenced from Gabapentin
Pregabalin
SKIP-PERMANENT
Gabapentinoid — α2δ voltage-gated calcium channel ligand (NOT GABAergic, NOT GABA-A active despite the name)
HIGH
L-Theanine
STRONG-CANDIDATE
Non-proteinogenic amino acid; glutamate / glutamine analog
HIGH
Propranolol
OPTIONAL-ADD
Non-selective beta-adrenergic blocker (β1 + β2 antagonist)
HIGH
Selank
STRONG-CANDIDATE
Russian-peptide (synthetic tuftsin analog, anxiolytic + immunomodulator + nootropic heptapeptide)
MEDIUM-HIGH
GHB / GBL
SKIP-PERMANENT
Endogenous GABA metabolite + GABA-B receptor agonist + GHB-receptor (GHBR / GPR172A) agonist; sodium oxybate is medical-grade GHB; GBL is the lipophilic lactone prodrug rapidly hydrolyzed to GHB by hepatic + serum lactonases; 1,4-butanediol is a separate prodrug oxidized via alcohol/aldehyde dehydrogenase to GHB
HIGH

More in Pharmaceutical · Oral

94 compounds in bucket
3-n-Butylphthalide (NBP)
OPTIONAL-ADD
Plant-derived multi-target neuroprotectant (phthalide; originally isolated from celery seed Apium graveolens); approved Chinese pharmaceutical for acute ischemic stroke
LOW
5-Amino-1MQ
WATCH-LIST
NNMT inhibitor (nicotinamide N-methyltransferase inhibitor) — small-molecule oral; methylation/NAD-sparing metabolic modulator
LOW
9-Methyl-β-carboline
WATCH-LIST
β-carboline alkaloid (tricyclic pyridoindole) — multimodal dopaminergic neurorestorative + dual MAO-A/B inhibitor + neurotrophic-factor inducer
LOW
ACD-856
WATCH-LIST
Pan-Trk receptor positive allosteric modulator (Trk-PAM) — small-molecule triazinetrione
HIGH
Adderall
SKIP-FOR-NOW
Amphetamine — substituted phenethylamine releasing agent (SNDRA)
MEDIUM
Adrafinil
SKIP-PERMANENT
Eugeroic — modafinil prodrug
HIGH